Literature DB >> 23823514

Ciliary body lymphangiogenesis.

Ludwig M Heindl, Falk Schrödl, Elke Lütjen-Drecoll, Claus Cursiefen.   

Abstract

Mesh：

Year:  2013        PMID： 23823514     DOI： 10.1016/j.ophtha.2013.03.039

Source DB:  PubMed          Journal:  Ophthalmology        ISSN： 0161-6420            Impact factor:   12.079


× No keyword cloud information.
  5 in total

1.  Lack of ciliary body lymphatics in iridociliary melanocytoma.

Authors:  Ludwig M Heindl; Franziska Bucher; Gottfried O H Naumann; Claus Cursiefen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-11-10       Impact factor: 3.117

Review 2.  Consensus statement on the immunohistochemical detection of ocular lymphatic vessels.

Authors:  Falk Schroedl; Alexandra Kaser-Eichberger; Simona L Schlereth; Felix Bock; Birgit Regenfuss; Herbert A Reitsamer; Gerard A Lutty; Kazuichi Maruyama; Lu Chen; Elke Lütjen-Drecoll; Reza Dana; Dontscho Kerjaschki; Kari Alitalo; Maria Egle De Stefano; Barbara M Junghans; Ludwig M Heindl; Claus Cursiefen
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-10-14       Impact factor: 4.799

3.  Absence of lymphatic vessels in non-functioning bleb capsules of glaucoma drainage devices.

Authors:  Robert Siggel; Falk Schroedl; Thomas Dietlein; Konrad R Koch; Christian Platzl; Alexandra Kaser-Eichberger; Claus Cursiefen; Ludwig M Heindl
Journal:  Histol Histopathol       Date:  2020-12-31       Impact factor: 2.303

Review 4.  Understanding lymphangiogenesis in knockout models, the cornea, and ocular diseases for the development of therapeutic interventions.

Authors:  Jessica F Yang; Amit Walia; Yu-hui Huang; Kyu-yeon Han; Mark I Rosenblatt; Dimitri T Azar; Jin-Hong Chang
Journal:  Surv Ophthalmol       Date:  2015-12-17       Impact factor: 6.048

Review 5.  Impact of the prolymphangiogenic crosstalk in the tumor microenvironment on lymphatic cancer metastasis.

Authors:  Simona L Schlereth; Nasrin Refaian; Sandra Iden; Claus Cursiefen; Ludwig M Heindl
Journal:  Biomed Res Int       Date:  2014-09-01       Impact factor: 3.411
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.